Abstract
Epidemiological analysis and mathematical models are now essential tools in understanding the dynamics of infectious diseases and in designing public health strategies to contain them. They have provided fundamental concepts, such as the basic and effective reproduction number, generation times, epidemic growth rates, and the role of pre-symptomatic infectiousness, which are crucial in characterising infectious diseases. These concepts are outlined and their relevance in designing control policies for outbreaks is discussed. They are illustrated using examples from the 2003 severe acute respiratory syndrome outbreak, which was brought under control within a year, and from pandemic influenza planning, where mathematical models have been used extensively.
Keywords: pandemic influenza, SARS, mathematical model
Introduction
The study of infectious diseases has been transformed by the use of mathematical models to gain insight into the dynamics of epidemics, to identify potential public health interventions, and to assess their impact.1 Mathematical models were useful in informing policy during the foot and mouth disease outbreak in the United Kingdom in 2001, during the severe acute respiratory syndrome (SARS) outbreak in 2003 and in recent planning of responses to potential smallpox or pandemic influenza outbreaks. These analyses and subsequent ongoing research have led to insights into epidemic dynamics and control, which have informed public health policy in this field. These results can often be presented in a technically complex or intimidating fashion, making the field inaccessible to non-specialists. This paper is designed to provide a non-technical summary of the core results and concepts for the non-specialist.
Mathematical models of epidemics rigorously represent our knowledge and assumptions about disease transmission. Models can range from simple systems of ordinary differential equations to complex individual-based stochastic simulations of millions of people.2 Depending on the quality and detail of data available, the models can represent variability in the disease course of individuals, as well as variability in spatial structure, demographic structure, population density, travel patterns, or treatment protocols.3 Model complexity is not, in itself, a virtue and indeed may not be necessary. The more intricate a model becomes, the more realism it can aspire to, but estimating parameters and interpretation of results is also increasingly difficult.
Models must be designed to make effective use of the available (and reliable) data and they must be tailored to answer clearly defined scientific or policy questions in a timely fashion. Epidemiological analyses allow quantification of characteristics such as mortality rates, incubation periods, and transmission rates; identification of disease transmission route(s), heterogeneities, and risk factors for disease spread; and the effectiveness of disease-control/risk-reduction policies. Analysis of well-constructed models can provide insight into the course of an epidemic and can be used to test ‘what if’ scenarios to inform the development of policy. In this paper, I outline important concepts of and insights on outbreaks of directly transmissible infections provided by quantitative approaches and epidemiological models, using examples from the 2003 SARS outbreak and recent analyses of a potential pandemic influenza outbreak.
Severe acute respiratory syndrome
The World Health Organisation (WHO) issued a global alert for SARS on 12 March 2003, at which point there were 150 suspected cases in seven countries (Figure 1).5 Although the disease had already spread to several countries across the globe, the epidemic was brought under control within a few months, with most of the 27 affected countries reporting fewer than 10 suspected cases. Epidemiological analysis and mathematical models played a crucial role in informing public health policy and contributing to the control of the outbreak.6, 7, 8 Effective international collaboration and data sharing facilitated rapid completion of most of the essential tasks, including identification of the aetiological agent.9
Influenza
The global spread of a highly pathogenic H5N1 influenza virus among wild fowl and domestic poultry flocks and the continuing occurrences of human cases4 poses the threat of a global influenza pandemic, should a strain emerge which is transmissible between humans. The 1918 influenza epidemic spread extremely rapidly and killed 20–40 million people worldwide. The world population has more than tripled since 1918, so high population densities, as well as increasing domestic and international travel, may facilitate such a pandemic. Improved surveillance, technological advances, and an increased understanding of epidemiology together enable societies to prepare for a range of possible pandemic scenarios. National governments and the WHO are monitoring human and avian cases of H5N1 and other novel strains,4 antiviral treatments are being produced in large quantities for stockpiling by governments10 and novel vaccines are being developed to protect against the avian form of the virus and being stockpiled by governments.10 Despite these precautions, the exact characteristics of a potentially pandemic strain which may emerge cannot be predicted exactly, although ranges can be estimated from previous pandemics.11, 12, 13 Therefore, it is essential to understand how the effects of such an outbreak might be contained, or at least mitigated, for a range of scenarios. Complex, often individual-based, models of influenza outbreaks, informed by re-analysis of previous pandemics, are being used to inform the design of public health strategies should a strain emerge which is capable of human-to-human transmission.2
Key Epidemiological Quantities
When faced with an emerging or re-emerging outbreak of an infectious disease, it is important to quantify the characteristics of the disease in order to evaluate the level of threat and the timescales over which the threat is likely to develop, and to consider possible methods of control. Accurate estimation of these characteristics depends on real time centralised collation of epidemiological information.
Basic reproduction number, R0
The basic reproduction number, R0, is typically defined as the mean number of new infections caused by a single infectious individual in a wholly susceptible population1 (the definition is slightly different for heterogeneous populations14). If each infected individual on average infects more than one other individual, that is, if R0 is greater than one, then a small number of cases in a population will usually lead to an epidemic. When there are small numbers of cases and R0 is large, there is a small probability that the epidemic will ‘fade-out’ after only a few infections because the early cases recover before infecting enough other individuals (Figure 2a). This probability of fading out before the epidemic takes off becomes smaller as R0 gets larger. If R0 is less than one the outbreak will surely die out. Infections with reproduction numbers close to, but exceeding, one are potentially easier to control than infections with reproduction numbers much larger than one.
The basic reproduction number for a particular infection is dependent on the biological characteristics of the disease and on the behavioural patterns of a population. The higher the transmission rate of the disease per unit time and the longer the duration of the infectious period, the larger the R0. A disease which is highly infectious for a short period of time may have the same basic reproduction number as a disease that is not as infectious but has a much longer infectious period. For diseases with similar characteristics the basic reproduction number is different for each population, as the opportunities for onward infection are affected by the contact patterns of a population. In a city where most people commute to work by public transport, for example, the opportunities for onward transmission of an airborne pathogen may be much greater than in less densely populated areas. For many directly transmitted diseases, such as measles1 and pandemic influenza,11 R0 is usually assumed to be similar in unvaccinated populations. For sexually transmitted diseases, large differences in sexual behaviour within populations can lead to estimates of R0 for heterosexual populations from 2 for low risk populations17 to over 10 for high activity groups and sex workers.18
Generation time, serial interval, Tg
Alongside the basic reproduction number, it is important to have some estimate of how quickly the number of cases of a novel infection will grow and how long an outbreak will last. The generation time, Tg, is defined as average time from an individual being infected to that individual infecting others.1, 14, 19, 20 This includes any latent period when the infected individual may not show symptoms or may not be infectious, and excludes any period when infected individuals may still be showing symptoms but are no longer infectious. It is sometimes assumed to be equivalent to the serial interval, which is the average time from when one person shows symptoms until the person they infect shows symptoms.20 For SARS this was initially estimated as 8–12 days.7, 21
Estimating R0 from the epidemic growth rate, r
When a novel infection is introduced to a population, there is a finite probability that it may not take hold in this population and die out, even if R0>1, because of the chance events when there are small numbers of infected individuals (Figure 2b). If, however, the infection takes hold, the number of new cases grows exponentially.1 The rate at which the number of cases will grow during this early stage, r, is dependent on both the reproduction number and the generation time of the infection, and can therefore be used to estimate the basic reproduction number. For a homogeneous population with onward infection occurring throughout the infectious period as R0=rTg+1, but there are other formulations for different model assumptions.1, 19, 22, 23 As for the basic reproduction number, the relationship between the epidemic growth rate, the serial interval, and the basic reproduction number is more complex for heterogeneous populations.14, 19 In Figure 2c I have used this equation to estimate R0 from first month of the SARS outbreak in Hong Kong in 2003 (Figure 2c). The best fitting straight line to the log incidence data gives a growth rate, r, of 0.15 per day (equivalent to a doubling time 4.6 days). The generation time of SARS, Tg, has been estimated to be 10 days from data on the number of days between the start of symptoms for individuals who infected each other.7, 24 We can now use the equation above to get an estimate of the basic reproduction number for SARS as R0=1+0.15 × 10=2.5. This relatively simple calculation gives a similar estimate to those made by more sophisticated methods.7, 21, 25
The basic reproduction number for influenza has been estimated to be as high as 21,26 but recent reanalysis of pandemic outbreaks estimate R0 for pandemic influenza to be in the range of 1.4–3.0,11, 12, 27 which is similar to that for SARS. The generation time for influenza is, however, much shorter than that for SARS, approximately 4–6 days,11, 27 which gives a doubling time of the epidemic of 1–4 days, much faster than was observed for SARS. This means that control of an outbreak of pandemic influenza will require very swift implementation of public health measures.
Effective reproduction number, R
During the course of an epidemic the effective reproduction number, R, is the average number of secondary cases per primary case at that point in the epidemic (Figure 2a). Estimation of this number during an epidemic facilitates quantitative assessment of the effectiveness of intervention strategies, with reduction below one meaning the outbreak being brought under control.25, 28 During the course of the SARS epidemic in 2003, mathematical modelling was an essential tool in showing that intervention methods gradually brought the epidemic under control in Hong Kong, Special Administrative Region of China and Singapore,7, 8, 25, 28 and that controls appear to have been lifted too early in Toronto, Canada.29 Reanalysis of the 1918–1919 influenza pandemic shows that public health measures were effective in mitigating this outbreak.30, 31, 32
Although R is an estimate of average transmission at a population level, individuals vary both in how they respond to an outbreak of a novel infection (such SARS) or an outbreak of a known infection (such as pandemic influenza), and in their behaviour in terms of the number of contacts that they make.14 Some individuals, termed ‘superspreaders’, may transmit to many others either because of some characteristic of their infection, because of their contacts or purely by chance – being in the wrong place at the right stage of their infection.7, 8, 33, 34, Care should be taken when gathering and interpreting data on possible exposures because they may be subject to bias towards previously identified sources and away from transmission from casual contacts; and may neglect asymptomatic transmissions.
Case fatality rate and age-distribution of cases
In assessing the potential consequences of an infectious disease outbreak, one of the most important concerns of policy makers is the number of fatalities. The case fatality rate (CFR) for a particular aetiological agent is the proportion of those who acquire the disease who will eventually die from it. In the early stages of an outbreak there will be many new cases of the disease for whom the outcome is not yet known and therefore estimates of the CFR must be carefully calculated.6, 35 In 2003 the WHO initially reported a CFR of 5 per cent,4 in fact the CFR for SARS was a much higher 15 per cent overall.6, 35
The overall CFR often hides large variations, with the young and the elderly often at highest risk. In the 2003 SARS outbreak in Hong Kong, the CFR was very low among the young (<1 per cent for ages <30 years) and increased to 55 per cent for patients over 60 years of age.15 Very few cases were admitted to hospital among the very young,6 which is unusual because children are often considered to be the group with the highest rate of transmission of directly transmitted pathogens, while also serving as a source of infection for their parents and other adults (sometimes called a ‘core group’).1 Serological surveys showed little evidence to support asymptomatic cases among this age group.
In the influenza pandemic of 1918, the CFR was much higher (∼3 per cent) in young adults aged 20–40 years than in non-pandemic years (<0.5 per cent).36 Also, those aged 5–14 years contributed disproportionately to the numbers of cases (∼25 per cent), but not to the numbers of deaths.36 There could be many possible explanations for these distributions, such as previous exposure to the pandemic strain, environmental factors, patterns of mixing and transmission because of the world war,36 or because of biological factors which could have made the virus so pathogenic overall (such as those discussed by Loo et al37). High numbers of cases and fatalities among the 20–40 age group are likely to have huge economic impact because they form an important part of the workforce, and are primary carers for children.
Public Health Interventions
Isolation and contact tracing
Isolation of symptomatic individuals together with tracing and quarantine of their contacts constitute major weapons in the armoury of public health outbreak control measures. The success of these strategies has been shown to be crucially dependent on the proportion of transmissions which occur before infected individuals show symptoms.26 Isolation of a proportion of symptomatic individuals can control an outbreak provided this proportion is large enough for that infection.26 Normally circulating influenza is believed to be infectious before the infected individual is showing symptoms,38 which makes control extremely difficult. If, however, the disease is mainly transmitted to close contacts, for example family members, then contact tracing may be manageable and effective. If transmission is likely for more casual contacts, contact tracing is much more difficult. Contact tracing has also been shown to depend on the degree of variability in the timing of infectiousness between different infected people in the population.39, 40 Before large amounts of resources are allocated, it may be important to assess the effectiveness of such a policy early in an epidemic through analysis of transmission chains and the impact of the intervention on the effective reproduction number.
Vaccination and prophylactic treatment
Both vaccination and prophylactic treatment with antiviral drugs or antibiotics restrict the spread of an infectious disease by limiting the number of individuals to whom the infection can be transmitted. Such strategies do not have to eliminate susceptibility from the population, but merely need to reduce the number of susceptible individuals so that the epidemic cannot be sustained. The minimum proportion of the population that must be vaccinated to prevent a large outbreak is 1−1/R0 for homogeneous populations.1 (There are also expressions for heterogeneous populations.41) This proportion is higher for diseases with large R0. The whole population need not be vaccinated, as those who are not vaccinated are protected by ‘herd immunity’, that is, the fact that the epidemic cannot be sustained in the population because there are so few susceptible individuals.
Limited vaccine and antivirals stockpiles available to governments may be employed in a number of ways, to those most at risk, to key workers, or to contain an outbreak. If antivirals are to be distributed prophylactically to prevent the spread of disease, rather than to treat cases, then containment may be possible, provided (i) there are enough doses or courses of treatment, (ii) the programme is implemented extremely rapidly, and (iii) cases are situated in a limited geographic region.11, 13, 40 The evolution of drug resistance would, of course, be a concern if large scale prophylaxis were implemented. Because of the short doubling time of influenza epidemics, these strategies would have to be implemented when there are very few cases. One such responsive strategy – implementing travel restrictions and prophylactic treatment of everyone within 10 km ring of each case – would require a stockpile of approximately 3 million courses of antiviral drugs to contain an outbreak of pandemic influenza.11 Following the publication of this analysis by Ferguson et al, Roche donated 3 million doses of their antiviral drug to the WHO for this very purpose and the WHO has set up project to develop protocols for practical implementation of containment.
Travel advisories and screening of passengers
International air travel greatly facilitates global spread of infectious diseases such as SARS and influenza.42, 43, 44, 45 The SARS epidemic of 2003 spread across the globe within a matter of days, eventually affecting 27 countries, with suspected cases reported in every populated continent (Figure 1). Public health measures, including screening and travel restrictions, can be put in place to slow this spread. The effectiveness of such methods, however, is dependent on the characteristics of the disease. If an infection has an incubation period which is longer than the duration of a flight then infected people are unlikely to develop symptoms during a flight. Thus even 100 per cent effective entry screening is unlikely to be useful in identifying cases.45 Imported SARS cases caused new outbreaks only in the early stages of the global outbreak, because of effective exchanges of information about the disease, the lack of pre-symptomatic infectiousness, and local outbreak control. If an outbreak is uncontrolled, then the number of new cases continues to grow exponentially and sheer weight of numbers means that cases will be exported. Travel reductions of greater than 99 per cent will be required to slow the spread of influenza.43, 44, 46, 47 Strategies aimed at protecting the public from pandemic influenza should focus resources on surveillance and rapid control of outbreaks wherever potentially pandemic strains arise.48
Summary
Epidemiological analyses and mathematical models are essential tools in understanding and controlling outbreaks of directly transmissible pathogens. There are many clinical and biological tasks to be completed, such as formulating a case definition and treatment strategies, identifying the aetiological agent and developing diagnostic tests. Alongside these tasks the estimation of key parameters, such as the basic and effective reproduction numbers, the generation time, and the proportion of transmissions occurring before symptoms, are essential to characterise an outbreak and its potential scope. Estimation of the effective reproduction number during an ongoing outbreak also provides an early indication of whether an infectious disease outbreak is under control or not. CFRs are an important consideration in public policy and must also be estimated accurately.
Epidemiological parameters cannot be estimated for outbreaks with new influenza strains until they actually emerge, but mathematical models can be used to investigate the likely consequences of a future influenza pandemic, based on analysis of previous epidemics and of current population structures and behaviours. Integration of epidemiological and statistical approaches increases the power of such analysis and the usefulness of models. Both statistical analyses and models require high quality epidemiological data, collected and collated centrally while the outbreak is ongoing and made available for analysis. Prediction of the exact progress of an epidemic will never be possible because of the variability of human behaviour. Nonetheless, mathematical models, which precisely represent knowledge and assumptions about disease transmission add significant insight into the dynamics of infectious diseases and are increasingly recognised as a vital part of any public health policy development.
Acknowledgements
The author would like to thank Roy Anderson, Ruth Chapman, Neil Ferguson, Christophe Fraser and Nicholas Grassly for helpful discussions, and Tom Johnston for assistance with Figure 1 and gratefully acknowledges funding from the EU Sixth Framework Programme for research for policy support (SARSTRANS, contact SP22-CT-2004-511066).
About the Author
Déirdre Hollingsworth is an epidemiological modeller at Imperial College London. She develops models for the design of effective interventions to control epidemic outbreaks of directly transmitted pathogens. Her research has included studies on the impact of international travel restrictions on the spread of pandemic influenza with Roy Anderson and Neil Ferguson. She studied mathematics and mathematical epidemiology at Oxford and Cambridge Universities, UK.
Footnotes
For non-specialists, this article offers an overview of the main concepts of infectious disease epidemiology and how the characteristics of an emerging infection determines the effectiveness of public health control options.
References
- Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. 1991. [Google Scholar]
- Riley S. Large-scale spatial-transmission models of infectious disease. Science. 2007;316(5829):1298–1301. doi: 10.1126/science.1134695. [DOI] [PubMed] [Google Scholar]
- Grassly NC, Fraser C. Mathematical models of infectious disease transmission. Nature Reviews Microbiology. 2008;6(6):477–487. doi: 10.1038/nrmicro1845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- World Health Organisation. (2008) Epidemic and pandemic response pages, http://www.who.int/csr/disease/avian_influenza/en/, accessed 24 March 2009.
- World Health Organisation. (2003) Summary of probable SARS cases with onset of illness from 1 Novemer 2002 to 31 July 2003, http://www.who.int/csr/sars/country/table20040421/en/, accessed 24 March 2009.
- Donnelly CA. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361(9371):1761–1766. doi: 10.1016/S0140-6736(03)13410-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lipsitch M. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300(5627):1966–1970. doi: 10.1126/science.1086616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Riley S. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science. 2003;300(5627):1961–1966. doi: 10.1126/science.1086478. [DOI] [PubMed] [Google Scholar]
- Peiris JS. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361(9366):1319–1325. doi: 10.1016/S0140-6736(03)13077-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mounier-Jack S, Jas R, Coker R. Progress and shortcomings in European national strategic plans for pandemic influenza. Bulletin of the World Health Organization. 2007;85(12):923–929. doi: 10.2471/BLT.06.039834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferguson NM. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437(7056):209–214. doi: 10.1038/nature04017. [DOI] [PubMed] [Google Scholar]
- Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature. 2004;432(7019):904–906. doi: 10.1038/nature03063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Longini IM., Jr. Containing pandemic influenza at the source. Science. 2005;309(5737):1083–1087. doi: 10.1126/science.1115717. [DOI] [PubMed] [Google Scholar]
- Diekmann O, Heesterbeek JAP. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation. 2000. [Google Scholar]
- Ferguson NM. Planning for smallpox outbreaks. Nature. 2003;425(6959):681–685. doi: 10.1038/nature02007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anderson RM. Epidemiology, transmission dynamics and control of SARS: The 2002–2003 epidemic. Philosophical Transactions of the Royal Society B: Biological Sciences. 2004;359(1447):105–1091. doi: 10.1098/rstb.2004.1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. Journal of Infectious Diseases. 2008;198(5):687–693. doi: 10.1086/590501. [DOI] [PubMed] [Google Scholar]
- Anderson RM. Populations and infectious-diseases – Ecology or epidemiology – The 8th Tansley lecture. Journal of Animal Ecology. 1991;60(1):1–50. doi: 10.2307/5443. [DOI] [Google Scholar]
- Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proceedings of the Royal Society B: Biological Sciences. 2007;274(1609):599–604. doi: 10.1098/rspb.2006.3754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fine PE. The interval between successive cases of an infectious disease. American Journal of Epidemiology. 2003;158(11):1039–1047. doi: 10.1093/aje/kwg251. [DOI] [PubMed] [Google Scholar]
- Riley S. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science. 2003;300(5627):1961–1966. doi: 10.1126/science.1086478. [DOI] [PubMed] [Google Scholar]
- Roberts MG, Heesterbeek JA. Model-consistent estimation of the basic reproduction number from the incidence of an emerging infection. Journal of Mathematical Biology. 2007;55(5–6):803–816. doi: 10.1007/s00285-007-0112-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Medicine. 2005;2(7):e174. doi: 10.1371/journal.pmed.0020174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donnelly CA. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infectious Diseases. 2004;4(11):672–683. doi: 10.1016/S1473-3099(04)01173-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. American Journal of Epidemiology. 2004;160(6):509–516. doi: 10.1093/aje/kwh255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences. 2004;101(16):6146–6151. doi: 10.1073/pnas.0307506101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Longini IM, Jr., Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. American Journal of Epidemiology. 2004;159(7):623–633. doi: 10.1093/aje/kwh092. [DOI] [PubMed] [Google Scholar]
- Cauchemez S. Real-time estimates in early detection of SARS. Emerging Infectious Diseases. 2006;12(1):110–113. doi: 10.3201/eid1201.050593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ofner-Agostini M. Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened? Canada Communicable Disease Report. 2008;34(2):1–11. [PubMed] [Google Scholar]
- Bootsma MC, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proceedings of the National Academy of Sciences USA. 2007;104(18):7588–7593. doi: 10.1073/pnas.0611071104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hatchett RJ, Mecher CE, Lipsitch M. Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proceedings of the National Academy of Sciences USA. 2007;104(18):7582–7587. doi: 10.1073/pnas.0610941104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chowell G, Nishiura H, Bettencourt LM. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. Journal of Royal Society Interface. 2007;4(12):155–166. doi: 10.1098/rsif.2006.0161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leung GM. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients. Annals of Internal Medicine. 2004;141(9):662–673. doi: 10.7326/0003-4819-141-9-200411020-00006. [DOI] [PubMed] [Google Scholar]
- Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355–359. doi: 10.1038/nature04153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghani AC. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. American Journal of Epidemiology. 2005;162:479–486. doi: 10.1093/aje/kwi230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taubenberger JK, Morens DM. 1918 influenza: The mother of all pandemics. Emerging Infectious Diseases. 2006;12(1):15–22. doi: 10.3201/eid1209.05-0979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loo YM, Gale M., Jr. Influenza: Fatal immunity and the 1918 virus. Nature. 2007;445(7125):267–268. doi: 10.1038/445267a. [DOI] [PubMed] [Google Scholar]
- Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: An evaluation of the evidence base. BMC Public Health. 2007;7:208. doi: 10.1186/1471-2458-7-208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klinkenberg D, Fraser C, Heesterbeek H. The effectiveness of contact tracing in emerging epidemics. PLoS ONE. 2006;1:e12. doi: 10.1371/journal.pone.0000012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu JT, Riley S, Fraser C, Leung GM. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine. 2006;3(9):e361. doi: 10.1371/journal.pmed.0030361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roberts MG, Heesterbeek JA. A new method for estimating the effort required to control an infectious disease. Proceedings of the Royal Society of London Series B: Biological Sciences. 2003;270(1522):1359–1364. doi: 10.1098/rspb.2003.2339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Colizza V, Barrat A, Barthelemy M, Vespignani A. The role of the airline transportation network in the prediction and predictability of global epidemics. Proceedings of the National Academy of Sciences USA. 2006;103(7):2015–2020. doi: 10.1073/pnas.0510525103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ. Delaying the international spread of pandemic influenza. PLoS Medicine. 2006;3(6):e212. doi: 10.1371/journal.pmed.0030212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hollingsworth TD, Ferguson NM, Anderson RM. Will travel restrictions control the international spread of pandemic influenza? Nature Medicine. 2006;12(5):497–499. doi: 10.1038/nm0506-497. [DOI] [PubMed] [Google Scholar]
- Pitman RJ, Cooper BS, Trotter CL, Gay NJ, Edmunds WJ. Entry screening for severe acute respiratory syndrome (SARS) or influenza: Policy evaluation. British Medical Journal. 2005;331(7527):1242–1243. doi: 10.1136/bmj.38573.696100.3A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferguson NM. Strategies for mitigating an influenza pandemic. Nature. 2006;442(7101):448–452. doi: 10.1038/nature04795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scalia Tomba G, Wallinga J. A simple explanation for the low impact of border control as a countermeasure to the spread of an infectious disease. Mathematical Biosciences. 2008;214(1–2):70–72. doi: 10.1016/j.mbs.2008.02.009. [DOI] [PubMed] [Google Scholar]
- Colizza V, Barrat A, Barthelemy M, Valleron AJ, Vespignani A. Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Medicine. 2007;4(1):e13. doi: 10.1371/journal.pmed.0040013. [DOI] [PMC free article] [PubMed] [Google Scholar]